HomeExamplesMCP & ModelsResearchDocumentationLoginBook a demo
HomeExamplesMCP & ModelsResearchDocumentationLoginBook a demo

KriSan Biotech

Ownership
Private
Employees
~60
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculePeptidesOligonucleotideAntibody-drug conjugatePeptide-drug conjugate (PDC)

KriSan Biotech General Information

KriSan Biotech is an integrated CDMO specializing in the development and cGMP manufacturing of APIs, peptides, oligonucleotides, ADCs, and high-potency drugs. The company supports pharmaceutical clients from preclinical through commercialization with strong expertise in process/analytical R&D and regulatory compliance. It has supplied clinical-stage materials for global partners up to Phase III trials and commercial launch support

Contact Information

Website
Primary Industry
Contract Manufacturing Organization
Corporate Office
Tainan, Tainan City
Taiwan

Drug Pipeline

No pipeline data available

For full access to KriSan Biotech's pipeline data

Book a demo

Key Partnerships

Atossa Genetics (API supply partner), OncoArendi Therapeutics (API supply partner)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

KriSan Biotech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view KriSan Biotech's complete valuation and funding history, request access »

KriSan Biotech Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals